Here are four notes:
1. The company has the high P/E ratio on Wall Street at 98.50. The P/E ratio is equal to a stock’s market capitalization divided by its after-tax earnings over a 12-month period.
2. The stock, currently at $99.49, is up 12.08 percent from its 52-week low.
3. The stock trades at an average volume of 1.18 million shares.
4. Zimmer Biomet’s key competitors include ConforMIS, LDR Holding and Globus Medical.
More articles on devices:
Grab some rays — Active individuals may need to maintain higher vitamin D levels to minimize stress fracture risk
Houston Methodis Hospital implements CT-free robotic surgery — 5 key points
OrthoSensor raises $3.9M in funding: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
